To maximize absorption and prevent the amino acids from competing with dietary proteins for transport across the intestinal wall, it is highly recommended to take glutathione between meals on an empty stomach
While this is the licensed indication, it's important to note that NICE guidance (TA875) recommends more specific criteria for NHS use: typically for people with a BMI 35 kg/m (lower thresholds may apply for some ethnic groups) with at least one weight-related comorbidity, prescribed within specialist weight management services, and limited to a maximum treatment duration of 2 years
Typical early side effects include nausea, appetite loss, mild digestive upset, and fatigue while the body adjusts to the dose
Hoping to manage your weight, but not on board to take GLP-1 agonists
Prognostic and therapeutic opportunities Prognosis A current limitation of many of the functional studies discussed in this review is that they are generally based only on cell biology experimentation, in some cases with pre-clinical confirmation in vivo